School of Medicine

Wayne State University School of Medicine

Copaxone Long Term Open-Label (Copaxone®) – Long term safety and efficacy study with Copaxone®- Closed to Enrollment

This is a trial which provides information regarding the long term safety of glatiramer acetate (Copaxone®) to a large number of patients for at least 15 years. Patients receive daily 20mg subcutaneous injections of glatiramer acetate.

Eligibility – Patients must have participated in the Copaxone Double-Blinded placebo controlled study.